Summary
MedAlliance is a developer of medical technology headquartered in Nyon, Switzerland. The company develops sirolimus micro-reservoir drug-coated balloon to treat patients suffering from peripheral artery disease (PAD), coronary artery disease (CAD), arteriovenous fistulas (AVF) and grafts (AVG) for end-stage renal disease.
Deals Overview
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
Senior Management
Jeffrey B. Jump
Chairman and CEO
Jean Pierre Pennacino
Vice President Finance
Richard Kenyon
Communications Director
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy